FILTER
LATEST ARTICLES
Safety in Turkish Mines
November 15, 2018
Turkish mining in the dock; recent disasters have cast a dark shadow over Turkish mining.
Prospective Lands: West Africa’s Mining Potential
November 15, 2018
GBR examines the current excitement surrounding the West African mining potential.
The Role of Women in Peru’s Mining Industry
November 06, 2018
by Lita Calenzani, President, Women in Mining Peru (WiM Peru)
Mining 2.0: Sustainable Cash Flows Has New Meaning
November 05, 2018
Dean McPherson defines ‘Mining 2.0’, a new era driven by responsible and innovation-driven mining.
Trade Agreements: USMCA replaces good old NAFTA
October 31, 2018
Bilateral trade between USA and Mexico will not be greatly damaged by the new regulations, but Mexico is nevertheless signing new trade agreements elsewhere to diversify its trade.
The Indispensable Partner: Contract Services
October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.
Latin American Petrochemicals: Decision Making Time
October 31, 2018
The region has resources and a growing demand, but faces political and infrastructure challenges.
Ghana: Breathing Life into a Maturing Sector
October 17, 2018
Ghana’s mining industry has seen a great deal of success, but the competitiveness of the region’s leading gold producer may wane as juniors pursue less-explored terrain in countries with greater incentives to invest in greenfield projects.
Global Reach: Ontario Mining’s International Presence
October 17, 2018
Home to the TSX and TSXV, both financial cornerstones of global mining, as well as a plethora of internationally focused mining companies, Ontario is a hub for global mining.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
